This federal contract award is for medical supplies and pharmaceutical products provided by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA). The $3,458.94 delivery order is for Linzess 290 MCG capsules and falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division. This IDC, which runs through November 2026, enables the government to procure a wide range of pharmaceutical and medical commodities to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating it was competitively awarded. In addition to the DLA contract, AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Generated 1/22/25, 9:12 AM